The Journal of Clinical and Translational Immunology (JCTI) serves as a leading platform for the dissemination of high-quality research that advances our understanding of the immune system and its direct impact on clinical practice. The journal’s primary aim is to bridge the gap between basic immunology discoveries and their translation into innovative diagnostics, therapeutic strategies, and public health applications.

✦ Aim:

JCTI aims to:

• Promote the integration of fundamental immunology with clinical sciences.
• Accelerate the translation of laboratory findings into patient-centered solutions.
• Encourage interdisciplinary research that connects immunology with biotechnology, pharmacology, genetics, and systems biology.
• Provide a global forum for the exchange of ideas, innovations, and best practices in immunological research and clinical care.

✦ Scope:

The journal welcomes original research articles, comprehensive reviews, case reports, short communications, and perspectives covering (but not limited to):

• Fundamental Immunology: Cellular and molecular mechanisms of innate and adaptive immunity, immune signaling, and host defense.
• Clinical Immunology: Immune dysregulation in human diseases, autoimmune disorders, hypersensitivity, allergy, and immune deficiencies.
• Translational Immunology: Development and evaluation of immunotherapies, vaccines, biologics, and cell-based therapies.
• Cancer Immunology: Tumor immunology, immune evasion, checkpoint inhibitors, CAR-T therapy, and combination strategies.
• Infectious Disease Immunology: Immune responses to viral, bacterial, fungal, and parasitic infections; vaccine research and development.
• Transplantation & Tolerance: Mechanisms of graft acceptance/rejection, tolerance induction, and immune monitoring in transplantation.
• Systems & Computational Immunology: Application of bioinformatics, artificial intelligence, and systems biology approaches to immunological data.
• Emerging Areas: Immunogenomics, microbiome–immune interactions, nanotechnology in immunology, and personalized immunomedicine.

✦ Audience:

The journal addresses a wide readership, including immunologists, clinicians, biomedical researchers, healthcare professionals, and policy makers who are engaged in advancing immunology research and its translation into real-world healthcare solutions.